General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0QDWDN
ADC Name
SC-005
Synonyms
SC-005; SC 005; SC005
   Click to Show/Hide
Organization
AbbVie, Inc.
Drug Status
Phase 1 (Terminated)
Indication
In total 1 Indication(s)
Breast cancer
Phase 1
Clinical Trial
Drug-to-Antibody Ratio
Undisclosed
Antibody Name
Undisclosed
Antigen Name
Undisclosed
Payload Name
PDB
 Payload Info 
Therapeutic Target
Human Deoxyribonucleic acid (hDNA)
 Target Info 
Linker Name
Undisclosed
Conjugate Type
Undisclosed